Crinetics Pharmaceuticals, Inc.
← Back to CRNX Overview

Crinetics Pharmaceuticals, Inc. (CRNX)

Solvency & Capital Structure

Total Debt

$47.9M

Net Debt

-$1.24B

Crinetics Pharmaceuticals, Inc. currently has $47.9M in total debt. Net debt is -$1.24B after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

CRNXQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.051.29-1.24Net Cash1.403.4%
2025-12-310.051.03-0.98Net Cash1.144.3%
2025-09-300.051.09-1.04Net Cash1.204.1%
2025-06-300.051.20-1.15Net Cash1.293.9%
2025-03-310.051.27-1.22Net Cash1.363.7%
2024-12-310.051.35-1.30Net Cash1.433.6%
2024-09-300.050.86-0.81Net Cash0.945.6%
2024-06-300.050.86-0.81Net Cash0.945.7%
2024-03-310.050.90-0.85Net Cash0.985.4%
2023-12-310.050.56-0.51Net Cash0.648.1%
2023-09-300.050.55-0.50Net Cash0.648.1%
2023-06-300.000.26-0.26Net Cash0.290.9%
2023-03-310.000.30-0.29Net Cash0.310.9%
2022-12-310.000.33-0.33Net Cash0.350.9%
2022-09-300.000.37-0.37Net Cash0.380.9%
2022-06-300.000.41-0.41Net Cash0.420.6%
2022-03-310.000.32-0.32Net Cash0.331.1%
2021-12-310.000.33-0.33Net Cash0.351.1%
2021-09-300.000.19-0.19Net Cash0.212.0%
2021-06-300.000.20-0.20Net Cash0.222.0%
2021-03-310.000.15-0.15Net Cash0.162.8%
2020-12-310.000.17-0.17Net Cash0.182.2%
2020-09-300.000.19-0.18Net Cash0.202.1%
2020-06-300.000.21-0.20Net Cash0.222.0%
2020-03-310.000.11-0.11Net Cash0.123.8%
2019-12-310.010.12-0.11Net Cash0.134.3%
2019-09-300.010.13-0.13Net Cash0.144.0%
2019-06-300.010.14-0.14Net Cash0.163.8%
2019-03-310.010.16-0.15Net Cash0.173.6%
2018-12-310.000.16-0.16Net Cash0.170.0%
2018-09-300.000.17-0.17Net Cash0.180.0%
2018-06-300.000.07-0.07Net Cash0.070.0%
2018-03-310.000.07-0.07Net Cash0.080.0%
2017-12-310.000.01-0.01Net Cash0.020.0%
2017-03-310.000.01-0.01Net Cash0.00